Factory Mutual Insurance Co. lifted its stake in shares of CVS Health Corporation (NYSE:CVS) by 0.7% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,415,500 shares of the pharmacy operator’s stock after buying an additional 10,000 shares during the period. CVS Health Corporation comprises approximately 1.3% of Factory Mutual Insurance Co.’s investment portfolio, making the stock its 14th biggest position. Factory Mutual Insurance Co. owned approximately 0.14% of CVS Health Corporation worth $113,892,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Mercer Capital Advisers Inc. acquired a new position in shares of CVS Health Corporation during the first quarter worth $118,000. SRS Capital Advisors Inc. increased its holdings in shares of CVS Health Corporation by 48.2% during the first quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock worth $177,000 after buying an additional 734 shares in the last quarter. Cue Financial Group Inc. increased its holdings in shares of CVS Health Corporation by 3.6% during the first quarter. Cue Financial Group Inc. now owns 2,708 shares of the pharmacy operator’s stock worth $213,000 after buying an additional 95 shares in the last quarter. Pettee Investors Inc. acquired a new position in shares of CVS Health Corporation during the first quarter worth $214,000. Finally, Diversified Trust Co acquired a new position in shares of CVS Health Corporation during the first quarter worth $229,000. Institutional investors own 81.55% of the company’s stock.

CVS has been the subject of several research analyst reports. Leerink Swann set a $90.00 price target on shares of CVS Health Corporation and gave the stock a “buy” rating in a report on Tuesday, June 27th. Guggenheim reiterated a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 3rd. Vetr downgraded shares of CVS Health Corporation from a “strong-buy” rating to a “buy” rating and set a $88.97 price target for the company. in a report on Monday, June 12th. Jefferies Group LLC reiterated a “hold” rating and set a $82.00 price target on shares of CVS Health Corporation in a report on Friday, July 14th. Finally, ValuEngine downgraded shares of CVS Health Corporation from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have issued a buy rating to the company’s stock. CVS Health Corporation has an average rating of “Buy” and an average price target of $90.35.

In related news, CFO David M. Denton sold 237,078 shares of the business’s stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $79.65, for a total transaction of $18,883,262.70. Following the transaction, the chief financial officer now owns 141,096 shares in the company, valued at $11,238,296.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Helena Foulkes sold 20,332 shares of the business’s stock in a transaction dated Monday, June 19th. The shares were sold at an average price of $76.98, for a total transaction of $1,565,157.36. Following the transaction, the executive vice president now owns 59,300 shares in the company, valued at approximately $4,564,914. The disclosure for this sale can be found here. Insiders have sold 611,660 shares of company stock worth $49,492,596 in the last quarter. 0.61% of the stock is owned by corporate insiders.

Shares of CVS Health Corporation (NYSE CVS) traded up 0.64% during mid-day trading on Friday, reaching $83.17. 7,483,230 shares of the company’s stock were exchanged. The company has a 50 day moving average price of $78.92 and a 200-day moving average price of $78.97. The stock has a market cap of $84.55 billion, a PE ratio of 16.57 and a beta of 0.92. CVS Health Corporation has a one year low of $69.30 and a one year high of $90.85.

CVS Health Corporation (NYSE:CVS) last released its quarterly earnings data on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.31 by $0.02. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The firm had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $45.36 billion. During the same quarter in the previous year, the company earned $1.32 earnings per share. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. On average, analysts predict that CVS Health Corporation will post $5.88 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This report was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright and trademark law. The original version of this report can be read at https://www.dailypolitical.com/2017/09/17/cvs-health-corporation-cvs-shares-bought-by-factory-mutual-insurance-co.html.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.